Advertisement
Research Article

Depressive Symptoms and Cortisol Rhythmicity Predict Survival in Patients with Renal Cell Carcinoma: Role of Inflammatory Signaling

  • Lorenzo Cohen mail,

    lcohen@mdanderson.org

    Affiliation: Department of General Oncology and the Integrative Medicine Program, The University of Texas MD Anderson Cancer Center, Houston, Texas, United States of America

    X
  • Steven W. Cole,

    Affiliation: Department of Medicine, Division of Hematology-Oncology, University of California Los Angeles School of Medicine, Los Angeles, California, United States of America

    X
  • Anil K. Sood,

    Affiliation: Department of Gynecologic Oncology and Cancer Biology Center for RNA Interference and Non-Coding RNA, The University of Texas MD Anderson Cancer Center, Houston, Texas, United States of America

    X
  • Sarah Prinsloo,

    Affiliation: Department of General Oncology and the Integrative Medicine Program, The University of Texas MD Anderson Cancer Center, Houston, Texas, United States of America

    X
  • Clemens Kirschbaum,

    Affiliation: Technical University of Dresden, Dresden, Germany

    X
  • Jesusa M. G. Arevalo,

    Affiliation: Department of Medicine, Division of Hematology-Oncology, University of California Los Angeles School of Medicine, Los Angeles, California, United States of America

    X
  • Nicholas B. Jennings,

    Affiliation: Department of Gynecologic Oncology and Cancer Biology Center for RNA Interference and Non-Coding RNA, The University of Texas MD Anderson Cancer Center, Houston, Texas, United States of America

    X
  • Shellie Scott,

    Affiliation: Department of Urology, The University of Texas MD Anderson Cancer Center, Houston, Texas, United States of America

    X
  • Luis Vence,

    Affiliation: Department of Melanoma Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas, United States of America

    X
  • Qi Wei,

    Affiliation: Department of General Oncology and the Integrative Medicine Program, The University of Texas MD Anderson Cancer Center, Houston, Texas, United States of America

    X
  • Diane Kentor,

    Affiliation: Department of Melanoma Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas, United States of America

    X
  • Laszlo Radvanyi,

    Affiliation: Department of Melanoma Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas, United States of America

    X
  • Nizar Tannir,

    Affiliation: Department of Genitourinary Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas, United States of America

    X
  • Eric Jonasch,

    Affiliation: Department of Genitourinary Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas, United States of America

    X
  • Pheroze Tamboli,

    Affiliation: Department of Pathology, The University of Texas MD Anderson Cancer Center, Houston, Texas, United States of America

    X
  • Louis Pisters

    Affiliation: Department of Urology, The University of Texas MD Anderson Cancer Center, Houston, Texas, United States of America

    X
  • Published: August 01, 2012
  • DOI: 10.1371/journal.pone.0042324

Viewed info

Cited info

Saved info

Discussed info

Questions or concerns about usage data? Please let us know.